Skip to main content
Fig. 4 | Cancer Cell International

Fig. 4

From: Construction of a prognostic model with histone modification-related genes and identification of potential drugs in pancreatic cancer

Fig. 4

Validation of the risk signature for the survival prediction in testing set, the entire TCGA set and the GSE57495 set. a, c, e Kaplan–Meier analysis of OS of the risk signature in testing set, the entire TCGA set and the GSE57495 set. b, d, f Time-dependent ROC analysis of the risk signature in testing set, the entire TCGA set and the GSE57495 set

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us